Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
9.86
+0.08 (0.82%)
Nov 13, 2026, 4:00 PM EST - Market closed
Contineum Therapeutics Market Cap
Contineum Therapeutics has a market cap or net worth of $387.16 million as of November 13, 2026. It is the 16,163rd most valuable company in the world and the 2,908th biggest in the United States. Its market cap has increased by 15.67% in one year.
Market Cap
387.16M
Enterprise Value
148.94M
1-Year Change
15.67%
Global Rank
Country Rank
#2,908 United States
Category
ChartMarket Cap Chart
Since the IPO on April 5, 2024, Contineum Therapeutics's market cap has decreased from $402.09M to $387.16M, a decrease of -3.71%. That is a compound annual growth rate of -1.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 387.16M | -7.27% |
| Dec 31, 2025 | 417.53M | 10.56% |
| Dec 31, 2024 | 377.64M | -6.08% |
| Apr 5, 2024 | 402.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aspen Neuroscience | 395.76M |
| MapLight Therapeutics | 392.92M |
| Opus Genetics | 392.42M |
| Lyell Immunopharma | 384.52M |
| ARS Pharmaceuticals | 383.01M |
| Fennec Pharmaceuticals | 382.23M |
| TRex Bio | 379.60M |
| CorMedix | 377.25M |